XML 35 R18.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Condensed Consolidated Financial Statement Detail (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2012
Condensed Consolidated Financial Statement Detail [Abstract] |
Outstanding securities considered anti-dilutive | Potentially dilutive securities are excluded from the calculation of loss per share if their inclusion is anti-dilutive. The following table shows the total outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2012 |  |  | 2011 |  |  | 2012 |  |  | 2011 |
Common stock options and restricted stock units |  |  | 5,730 |  |  |  | 4,036 |  |  |  | 5,788 |  |  |  | 3,837 |
Convertible preferred stock |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 90 |
Warrants for common stock |  |  | 16,626 |  |  |  | 1,608 |  |  |  | 12,942 |  |  |  | 1,608 |
Total |  |  | 22,356 |  |  |  | 5,644 |  |  |  | 18,730 |  |  |  | 5,535 |
Accrued liabilities | Accrued liabilities consisted of the following at September 30, 2012 and December 31, 2011 (in thousands):
|  | September 30, 2012 |  |  | December 31, 2011 |
Accrued management incentive compensation |  | $ | 2,821 |  |  | $ | 4,096 |
Accrued payroll and other benefits |  |  | 2,510 |  |  |  | 3,007 |
Accrued clinical trial costs |  |  | 3,940 |  |  |  | 140 |
Accrued severance payments |  |  | 642 |  |  |  | 1,207 |
Other |  |  | 1,754 |  |  |  | 1,562 |
Total |  | $ | 11,667 |  |  | $ | 10,012 |

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | xoma_CondensedConsolidatedFinancialStatementDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration